Inhibition of cyclic AMP-dependent kinase by expression of a protein kinase inhibitor/enhanced green fluorescent fusion protein attenuates angiotensin II-induced type 1 AT1 receptor mRNA down-regulation in vascular smooth muscle cells

Molecular Pharmacology

Volumn 54, Issue 3, 1998, Pages 514-524

  Wang, Xiaofei ^a   Murphy, T J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN KINASE INHIBITOR;

AGONIST; ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0031693459     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.3.514     Document Type: Article

References (30)

1. Brasier AR, Tate JE, and Habener JF (1989) Optimized use of the firefly luciferase assay as a reporter in mammalian cell lines. Biotechniques 7:1116-1122.
2. Chen C and Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
3. Corbin JD (1983) Determination of the cAMP-dependent protein kinase activity ratio in intact tissues. Methods Enzymol 99:227-232.
4. Cormack BP, Valdivia RH, and Falkow S (1996) FACS-optimized mutants of the green fluorescent protein (GFP) Gene 173:33-38.
5. Dubois M-F, Nguyen VT, Bellier S, and Bensaude O (1994) Inhibitors of transcription such as 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit. J Biol Chem 269:13331-13336.
6. Emerman M and Temin HM (1984) Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:459-467.
7. Engh RA, Girod A, Kinzel V, Huber R, and Bossemeyer D (1996) Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8 and H89. J Biol Chem 271:26157-26164.
8. Fantozzi DA, Harootunian AT, Wen W, Taylor SS, Feramisco JR, Tsien RY, and Meinkoth JL (1994) Thermostable inhibitor of cAMP-dependent protein kinase enhances the rate of export of the kinase catalytic subunit from the nucleus. J Biol Chem 269:2676-2686.
9. i in living fibroblasts. Exp Cell Res 195:468-477.
10. Glass DB, Cheng HC, Kemp BE, and Walsh DA (1986) Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem 261:12166-12171.
11. Gossen M and Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
12. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, and Krebs EG (1996) Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem 271:505-511.
13. Grieco D, Porcellini A, Avvedimento EV, and Gottesman ME (1996) Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase. Science (Washington DC) 271:1718-1723.
14. Grove JR, Price DJ, Goodman HM, and Avruch J (1987) Recombinant fragment of protein kinase inhibitor blocks cyclic AMP-dependent gene transcription. Science (Washington DC) 238:530-533.
15. Harris TE, Persaud SJ, and Jones PM (1997) Pseudosubstrate inhibition of cyclic AMP-dependent protein kinase in intact pancreatic islets: effects on cyclic AMP-dependent and glucose-dependent insulin secretion. Biochem Biophys Res Commun 232:648-651.
16. Hill CS and Treisman R (1995) Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211.
17. Kotani H Newton PB, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, and McGarrity GJ (1994) Improved methods for retroviral vector transduction and production for gene therapy. Hum Gene Ther 5:19-28.
18. 1 receptor by transcriptional and post-transcriptional mechanisms: evidence of homologous and heterologous regulation. Mol Pharmacol 48:601-609.
19. Li X, Van Putten V, Zarinetchi F, Nicks ME, Thaler S, Heasley LE, and Nemenoff RA (1997). Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2. Biochem J 327: 709-716.
20. Miller AD, Miller DG, Garcia JV, and Lynch CM (1993) Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217:581-599.
21. Murphy TJ, Alexander RW, Griendling KK, Runge MS, and Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (Lond) 351:233-236.
22. Nickenig G and Murphy TJ (1994) Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol Pharmacol 46:653-659.
23. Nickenig G and Murphy TJ (1996) Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol Pharmacol 50:743-751.
24. Rainey WE, Byrd EW, Sinnokrot RA, and Carr BR (1991) Angiotensin-II activation of cAMP and corticosterone production in bovine adrenocortical cells: effects of nonpeptide angiotensin-II antagonists. Mol Cell Endocrinol 81:33-41.
25. Shimizu H, Daly JW, and Creveling CR (1969) A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. JNeurochem 16:1609-1619.
26. 1a angiotensin receptor gene. Circ Res 73:612-621.
27. Temin HM (1986) Retrovirus vectors for gene transfer: efficient integration into and expression of exogenous DNA in vertebrate cell genomes, in Gene Transfer (Kucherlapati R, ed) pp 149-187, Plenum Press, New York.
28. Walsh DA, Angelos KL, Van Patten SM, Glass DB, and Garetto LP (1990) The inhibitor of the cAMP-dependent protein kinase, in Peptides and Protein Phosphorylation (Kemp BE, ed) pp 43-84, CRC Press, Boca Raton, FL.
29. Wang X-F, Nickenig G, and Murphy TJ (1997) The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cAMP-elevating agents. Mol Pharmacol 52:781-787.
30. Wen W, Meinkoth JL, Tsien RY, and Taylor SS (1995) Identification of a signal for rapid export of protein from the nucleus. Cell 82:463-473.